| Description |
1 online resource (xix, 351 pages) : illustrations. |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
| Series |
Heterocyclic drug discovery series |
|
Heterocyclic drug discovery.
|
| Bibliography |
Includes bibliographical references and index. |
| Contents |
2.3.5 Using benzil, aldehyde, and ammonium acetate -- 2.4 Tetra-substituted imidazole derivatives -- 2.4.1 Using aminoethylpiperazine -- 2.4.2 Using prop-2-ynylamine -- 2.4.3 Using benzil, aldehydes, ammonium acetate, and aniline -- 3 Imidazole hybrids -- 3.1 Imidazole fused heterocycles -- 3.2 Benzimidazole fused heterocycles -- 4 Benzimidazole -- 4.1 Hoebrecker synthesis -- 4.2 Synthesis of benzimidazoles using o -phenylenediamine and acids -- 4.3 Synthesis of benzimidazoles using o -phenylenediamine and acid anhydride -- 4.4 Synthesis of benzimidazoles using o -phenylenediamine and alcohols |
|
4.5 Synthesis of benzimidazoles using o -phenylenediamine and alkyl halides -- 4.6 Synthesis of benzimidazoles using ketones -- 4.7 Synthesis of benzimidazoles using o -phenylenediamine and aldehydes -- 5 Conclusion -- Conflict of interest -- Acknowledgments -- Funding source -- References -- Chapter 2 Biological profile of imidazole-based compounds as anticancer agents -- 1 Introduction -- 2 Imidazole-based heterocycles -- 2.1 Imidazole as the main nucleus in the anticancer compounds -- 2.1.1 Mono-substituted imidazole derivatives -- 2.1.2 Disubstituted imidazole derivatives |
|
2.1.3 Trisubstituted imidazole derivatives -- 2.1.4 Tetra-substituted imidazole derivatives -- 2.2 Imidazole hybrids as anticancer agents -- 2.3 Imidazole fused heterocycles -- 2.3.1 Imidazole fused heterocycles -- 2.3.2 Benzimidazole fused heterocycles -- 2.4 Imidazole-based metal complexes as anticancer agents -- 3 Conclusion and future challenges -- Conflict of interest -- Acknowledgment -- Funding source -- References -- Chapter 3 Recent advancements on imidazole containing heterocycles as antitubercular agents -- 1 Introduction -- 2 Imidazole-based heterocycles -- 2.1 Substituted imidazoles |
|
2.2 Hybrid Imidazoles -- 2.3 Fused imidazoles -- 2.4 Linker imidazole -- 2.5 Benzimidazole -- 3 Conclusion -- Conflict of interest -- Acknowledgments -- Funding source -- References -- Chapter 4 Imidazole derivatives: Impact and prospects in antiviral drug discovery -- 1 Introduction -- 2 Imidazole derivatives and their action against different viruses -- 2.1 Zika virus -- 2.2 Influenza -- 2.3 SARS-COVID -- 2.4 Dengue -- 2.5 Hepatitis -- 2.6 HIV -- 2.7 Miscellaneous -- 3 Conclusion -- Acknowledgments -- Conflict of interest -- Funding source -- References |
| Note |
Chapter 5 Imidazole heterocycles: Therapeutically potent lead compounds as antimicrobials. |
|
Online resource; title from PDF title page (ScienceDirect platform, viewed April 19, 2022). |
| Subject |
Imidazoles.
|
|
Drugs.
|
|
Drug development.
|
|
Imidazoles |
|
Pharmaceutical Preparations |
|
Imidazole.
|
|
Médicaments.
|
|
Médicaments -- Développement.
|
|
Drug development
|
|
Drugs
|
|
Imidazoles
|
| Other Form: |
Print version: 0323854796 (OCoLC)1257403690 |
| ISBN |
9780323903639 |
|
0323903630 |
|
9780323854795 |
| Standard No. |
AU@ 000070668214 |
|
AU@ 000073114593 |
|
